Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 218
-1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis

Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...

Postpartum Mental Health Needs of Hispanic Mothers

Postpartum mood disorders represent a critical public health issue affecting mothers and their children...

Assessing Guadalupe Fur Seal Health and Ecology

A multidisciplinary team of researchers will assess the health of Guadalupe fur seal pups and adults by...

Backer Badge Funded